Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSR125543 in Major Depressive Disorder
NCT01034995Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of crinecerfont in major depressive disorder (MDD), sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
crinecerfont
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01034995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034995.